Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome
|ClinicalTrials.gov Identifier: NCT01603745|
Recruitment Status : Unknown
Verified May 2012 by Rosanna Apa, Catholic University of the Sacred Heart.
Recruitment status was: Recruiting
First Posted : May 22, 2012
Last Update Posted : May 22, 2012
Catholic University of the Sacred Heart
Information provided by (Responsible Party):
Rosanna Apa, Catholic University of the Sacred Heart
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Actual Primary Completion Date :||May 2012|
|Estimated Study Completion Date :||October 2012|
Publications of Results:
Niccoli G, Apa R, Lanzone A, Liuzzo G, Spaziani C, Sagnella F, Cosentino N, Moro F, Martinez D, Morciano A, Bacà M, Pazzano V, Gangale MF, Tropea A, Crea F. CD4+CD28 null T lymphocytes are expanded in young women with polycystic ovary syndrome. Fertil Steril. 2011 Jun 30;95(8):2651-4. doi: 10.1016/j.fertnstert.2011.01.129. Epub 2011 Feb 16.